Table 2.
Endoscopic Findings and Clinical Features of Patients with Advanced Disease
| No. | Final diagnosis |
Endoscopic finding |
Age (yr) |
Sex | Indication | Duration between diagnosis of LLH and advanced disease (mo) | Initial pathologic diagnosis |
|---|---|---|---|---|---|---|---|
| 1 | UC | Nodular type | 50 | Male | Screening | 12 | Lymphoid follicle |
| 2 | UC | Nodular type | 39 | Female | FOBT (+) | 15 | Lymphoid follicle |
| 3 | UC | Nodular type | 56 | Female | Blood tinged stool | 14.6 | Diffuse active inflammation with focal cryptitis and lymphoid aggregates |
| 4 | UC | Nodular type | 27 | Female | Hematochezia | 16 | Lymphoid follicle |
| 5 | UC | Nodular type | 28 | Female | Blood tinged stool | 6.3 | Focal active inflammation with cryptitis and lymphoid aggregates |
| 6 | MALT lymphoma |
SMT-like type | 68 | Female | Screening (endoscopic resection) | 17 | Lymphoid follicle |
LLH, localized lymphoid hyperplasia; UC, ulcerative colitis; FOBT, fecal occult blood test; MALT, mucosa-associated lymphoid tissue; SMT, submucosal tumor.